{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:34:58Z","timestamp":1765546498494,"version":"3.41.2"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115337"],"award-info":[{"award-number":["115337"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["105620\/Z\/14\/Z"],"award-info":[{"award-number":["105620\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation | Medical Research Council","doi-asserted-by":"publisher","award":["G1002586","MR\/N028376\/1","MC_PC_14111"],"award-info":[{"award-number":["G1002586","MR\/N028376\/1","MC_PC_14111"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,12,20]]},"abstract":"<jats:p>Clinical studies of new antitubercular drugs are costly and time-consuming. Owing to the extensive tuberculosis (TB) treatment periods, the ability to identify drug candidates based on their predicted clinical efficacy is vital to accelerate the pipeline of new therapies. Recent failures of preclinical models in predicting the activity of fluoroquinolones underline the importance of developing new and more robust predictive tools that will optimize the design of future trials.<\/jats:p>","DOI":"10.1128\/aac.00989-19","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T12:46:28Z","timestamp":1570711588000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Intracellular Pharmacodynamic Modeling Is Predictive of the Clinical Activity of Fluoroquinolones against Tuberculosis"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3903-5150","authenticated-orcid":false,"given":"Samantha","family":"Donnellan","sequence":"first","affiliation":[{"name":"Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghaith","family":"Aljayyoussi","sequence":"additional","affiliation":[{"name":"Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Moyo","sequence":"additional","affiliation":[{"name":"Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Ardrey","sequence":"additional","affiliation":[{"name":"Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Martinez-Rodriguez","sequence":"additional","affiliation":[{"name":"Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Ward","sequence":"additional","affiliation":[{"name":"Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6356-6595","authenticated-orcid":false,"given":"Giancarlo A.","family":"Biagini","sequence":"additional","affiliation":[{"name":"Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"Tuberculosis global report","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. 2017. Tuberculosis global report. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.8.2066"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.1.85"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-8579(02)00239-x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.47.1.360-362.2003"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200310-1380OC"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0085-2015"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315817"},{"key":"e_1_3_3_10_2","first-page":"128","article-title":"A phase II study of the sterilizing activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis","volume":"12","author":"Rustomjee R","year":"2008","unstructured":"Rustomjee R, Lienhardt C, Kanyok T, Davies GR, Levin J, Mthiyane T, Reddy C, Sturm AW, Sirgel FA, Coleman AJ, Fourie DJ, Mitchison B, Gatifloxacin For DA, Study Team TB. 2008. A phase II study of the sterilizing activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 12:128\u2013138.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60333-0"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407426"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-360OC"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.05.003"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12472"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01370-15"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00912-12"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1210OC"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pit077"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1029OC"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ911"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314210"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00529-6"},{"key":"e_1_3_3_24_2","first-page":"979","article-title":"Effect of rifampicin and isoniazid on the steady state pharmacokinetics of moxifloxacin","volume":"136","author":"Ramachandran G","year":"2012","unstructured":"Ramachandran G, Hemanth Kumar AK, Srinivasan R, Geetharani A, Sugirda P, Nandhakumar B, Nandini R, Tharani CB. 2012. Effect of rifampicin and isoniazid on the steady state pharmacokinetics of moxifloxacin. Indian J Med Res 136:979\u2013984.","journal-title":"Indian J Med Res"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/521894"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.2165\/11594090-000000000-00000"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00133-06"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.13-0603"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ195"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01780-07"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2015.02.037"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11060278"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00414-06"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1155\/1999\/378394"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201303-0604OC"},{"key":"e_1_3_3_36_2","first-page":"605","article-title":"Early and extended early bactericidal activity of levofloxacin, gatifloxacin, and moxifloxacin in pulmonary tuberculosis","volume":"10","author":"Johnson JL","year":"2006","unstructured":"Johnson JL, Hadad DJ, Boom WH, Daley CL, Peloquin CA, Eisenach KD, Jankus DD, Debanne SM, Charlebois ED, Maciel E, Palaci M, Dietze R. 2006. Early and extended early bactericidal activity of levofloxacin, gatifloxacin, and moxifloxacin in pulmonary tuberculosis. Int J Tuber Lung Dis 10:605\u2013612.","journal-title":"Int J Tuber Lung Dis"},{"key":"e_1_3_3_37_2","first-page":"1943","article-title":"Recent advances in tuberculosis: new drugs and treatment regimens","volume":"9","author":"Sloan DJ","year":"2001","unstructured":"Sloan DJ, Davies GR, Khoo SH. 2001. Recent advances in tuberculosis: new drugs and treatment regimens. Antimicrob Agents Chemother 9:1943\u20131946.","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129744"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2013.072"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0585-7"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0224-2"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1017\/s002217240001158x"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/108705719900400206"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1915"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2009.11.020"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.4049\/jimmunol.162.11.6740","article-title":"Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates","volume":"162","author":"Manca C","year":"1999","unstructured":"Manca C, Tsenova L, Barry CE, III, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G. 1999. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 162:6740\u20136746.","journal-title":"J Immunol"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.6.835"},{"key":"e_1_3_3_48_2","volume-title":"A language and environment for statistical computing","author":"R Core Team","year":"2015","unstructured":"R Core Team. 2015. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria."},{"key":"e_1_3_3_49_2","volume-title":"Principal component analysis","author":"Joliffe I","year":"2004","unstructured":"Joliffe I. 2004. Principal component analysis, 2nd ed. Springer, New York, NY.","edition":"2"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00989-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00989-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T13:01:18Z","timestamp":1695301278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00989-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12,20]]}},"alternative-id":["10.1128\/AAC.00989-19"],"URL":"https:\/\/doi.org\/10.1128\/aac.00989-19","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"type":"print","value":"0066-4804"},{"type":"electronic","value":"1098-6596"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"2019-05-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00989-19"}}